0001691855-16-000001.txt : 20161208 0001691855-16-000001.hdr.sgml : 20161208 20161208150126 ACCESSION NUMBER: 0001691855-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161208 DATE AS OF CHANGE: 20161208 EFFECTIVENESS DATE: 20161208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trefoil Therapeutics, Inc. CENTRAL INDEX KEY: 0001691855 IRS NUMBER: 465393995 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-275923 FILM NUMBER: 162041262 BUSINESS ADDRESS: STREET 1: 4868 ALMONDWOOD WAY CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 917-628-8502 MAIL ADDRESS: STREET 1: 4868 ALMONDWOOD WAY CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0707 D LIVE 0001691855 Trefoil Therapeutics, Inc. 4868 ALMONDWOOD WAY SAN DIEGO CA CALIFORNIA 92130 917-628-8502 DELAWARE Trefoil Therapeutics, LLC None Corporation true 2016 David Eveleth c/o Trefoil Therapeutics, Inc. 4868 Almondwood Way San Diego CA CALIFORNIA 92130 Executive Officer Director Ralph Bradshaw c/o Trefoil Therapeutics, Inc. 4868 Almondwood Way San Diego CA CALIFORNIA 92130 Director Schalon Newton c/o Trefoil Therapeutics, Inc. 4868 Almondwood Way San Diego CA CALIFORNIA 92130 Executive Officer Christy Shaffer c/o Trefoil Therapeutics, Inc. 4868 Almondwood Way San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06b false 2016-12-01 false true false 0 5164000 4163999 1000001 $164,000.00 in conversion of promissory notes; $3,999,999.62 in new money. false 14 0 0 0 false Trefoil Therapeutics, Inc. /s/ David Eveleth David Eveleth Chief Executive Officer 2016-12-08